Cognitio develops a non-invasive medical device that utilizes neuroacoustic technology to modulate brain oscillations during sleep, targeting various neurological conditions. This approach offers personalized treatment solutions that enhance sleep quality and improve neurological health without disrupting daily routines.
Funding
Funding not disclosed
Founders
Product
Problem
Many neurological conditions lack effective, non-invasive treatments that can be easily integrated into a patient's daily life. Current treatments may involve medication with side effects or therapies that require significant time commitments and lifestyle disruptions. This creates a need for accessible, personalized solutions that can improve neurological health without impacting daily routines.
Solution
Cognitio develops a neuroacoustic medical device designed to modulate brain oscillations during sleep, offering a non-invasive treatment approach for various neurological conditions. The device utilizes sound waves to influence brain activity, aiming to enhance sleep quality and address underlying neurological issues. By using the device during sleep, patients can receive treatment without disrupting their daily activities. The company focuses on providing personalized treatment solutions tailored to each individual's specific needs, potentially leading to more effective and sustainable outcomes.
Target Audience
The primary target audience includes individuals with neurological conditions seeking non-invasive treatment options, as well as healthcare providers looking for innovative solutions to improve patient outcomes.
Features
- Neuroacoustic technology to modulate brain oscillations during sleep
- Personalized treatment solutions tailored to individual needs
- Non-invasive approach that does not disrupt daily routines
- Designed to enhance sleep quality and improve neurological health